Pulmonary Hypertension Global Clinical Trials Review, H1, 2012
Pulmonary Hypertension Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, H1, 2012" provides data on the Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Summary
GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, H1, 2012" provides data on the Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents
IntroductionPulmonary Hypertension
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Pulmonary Hypertension
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Pulmonary Hypertension Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Actelion Ltd
Clinical Trial Overview of Actelion Ltd
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
United Therapeutics Corporation
Clinical Trial Overview of United Therapeutics Corporation
Bayer AG
Clinical Trial Overview of Bayer AG
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Novartis AG
Clinical Trial Overview of Novartis AG
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Lung Rx, Inc.
Clinical Trial Overview of Lung Rx, Inc.
INO Therapeutics, LLC
Clinical Trial Overview of INO Therapeutics, LLC
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
EPIX Pharmaceuticals, Inc. (Inactive)
Clinical Trial Overview of EPIX Pharmaceuticals, Inc. (Inactive)
Nippon Shinyaku Co., Ltd.
Clinical Trial Overview of Nippon Shinyaku Co., Ltd.
GENO Pharmaceuticals Ltd.
Clinical Trial Overview of GENO Pharmaceuticals Ltd.
Encysive Pharmaceuticals Inc.
Clinical Trial Overview of Encysive Pharmaceuticals Inc.
Berlin Chemi AG
Clinical Trial Overview of Berlin Chemi AG
Children's Healthcare of Atlanta Inc.
Clinical Trial Overview of Children's Healthcare of Atlanta Inc.
Medtronic Cardiac Rhythm Disease Management
Clinical Trial Overview of Medtronic Cardiac Rhythm Disease Management
Clinical Trial Overview of Top Universities / Institutes / Hospitals
University of Heidelberg
Clinical Trial Overview of University of Heidelberg
Keio University
Clinical Trial Overview of Keio University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
The Medical University of Graz
Clinical Trial Overview of The Medical University of Graz
The University of Chicago
Clinical Trial Overview of The University of Chicago
North Shore Long Island Jewish Health System
Clinical Trial Overview of North Shore Long Island Jewish Health System
University of Cincinnati
Clinical Trial Overview of University of Cincinnati
The Cleveland Clinic
Clinical Trial Overview of The Cleveland Clinic
Rabin Medical Center
Clinical Trial Overview of Rabin Medical Center
University of Oxford
Clinical Trial Overview of University of Oxford
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
Imperial College London
Clinical Trial Overview of Imperial College London
The Children's Hospital of Philadelphia
Clinical Trial Overview of The Children's Hospital of Philadelphia
Aarhus University
Clinical Trial Overview of Aarhus University
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Duke University
Clinical Trial Overview of Duke University
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Radboud University
Clinical Trial Overview of Radboud University
Department of Defence
Clinical Trial Overview of Department of Defence
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, BRIC Countries, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, G7 Countries, 2012*
Pulmonary Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, E7 Countries, 2012*
Pulmonary Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Lung Rx, Inc., 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by INO Therapeutics, LLC, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by EPIX Pharmaceuticals, Inc. (Inactive), 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Shinyaku Co., Ltd., 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GENO Pharmaceuticals Ltd., 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Encysive Pharmaceuticals Inc., 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Berlin Chemi AG, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic Cardiac Rhythm Disease Management, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by North Shore Long Island Jewish Health System, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Defence, 2012*
LIST OF FIGURES
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, G7 Countries (%), 2012*
Pulmonary Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, E7 Countries (%), 2012*
Pulmonary Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top